Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

7 Insider Moves You Should Pay Attention To

Insider trades: There are dozens of insider trades made each week, and reported to the SEC, which are then made public. Let’s take a look at seven of the most important you should be paying attention to.

Insider Trading 3

Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), bought 1,000 shares. The move came amid safety and efficiency reports from Repros about its new drug, Androxal, which is being developed for testosterone development in men.

KB Home (NYSE:KBH) was also in the middle of two insider transactions recently.  Thomas S Silk, SVP of Marketing and Communications, acquired 5,000 shares of common stock, at a price of $6.04 apiece, with the value of the deal amounting to $30,200. Jeffrey T. Mezger, President and CEO at KB Home, bought 150,000 shares, and Jeff Kaminski, EVP & Chief Financial Officer, acquired 15,000 shares.

John A. Crum, Chairman, President and CEO of Midstates Petroleum Company Inc (NYSE:MPO), increased his position in the company by 10,000 shares, to 1.3 million total.

J Michael Ancius, Director at Fastenal Company (NASDAQ:FAST), now holds 6,600 shares, worth $317,130. The trades were made at a price of $47.91 per share.

A director at Century Bancorp, Inc. (NASDAQ:CNBKA), Marshall M. Sloane, bought 304 shares, increasing his holdings slightly.

Markel Corporation (NYSE:MKL)’s director, D Darrell Martin, bought 150 shares at a price of $538.30 a pop.

Three insiders at Occidental Petroleum bought in: VP James Lienert, VP Edward Lowe and VP Controller Pineci Roy.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!